Development and Validation of an RP-HPLC Method for Estimation of Related Substances of Tetracycline Hydrochloride 1% w/w Ophthalmic Ointment: A Review

https://doi.org/10.61096/ijphr.v14.iss4.2026.1054-1065

Authors

  • Aishwarya Department of Pharmaceutical Analysis, Sarojini Naidu Vanita Pharmacy Maha Vidyalaya (Co-Ed.), Tarnaka, Secunderabad, Telangana, India
  • Duddagi Suchitra Department of Pharmaceutical Analysis, Sarojini Naidu Vanita Pharmacy Maha Vidyalaya (Co-Ed.), Tarnaka, Secunderabad, Telangana, India
  • P. Vivek Sagar Department of Pharmaceutical Analysis, Sarojini Naidu Vanita Pharmacy Maha Vidyalaya (Co-Ed.), Tarnaka, Secunderabad, Telangana, India

Keywords:

Tetracycline hydrochloride, ophthalmic ointment, related substances, 4-epianhydrotetracycline, RP-HPLC, stability-indicating method, ICH Q2(R2)

Abstract

Tetracycline hydrochloride 1% w/w eye ointment is a WHO essential medicine for superficial bacterial eye infections and neonatal conjunctivitis prophylaxis. Tetracycline degrades readily by C4-epimerisation and C6-dehydration to 4-epitetracycline (ETC), anhydrotetracycline (ATC) and the nephrotoxic 4-epianhydrotetracycline (EATC), and it carries the fermentation impurities 2-acetyl-2-decarboxamidotetracycline (ADTC) and chlortetracycline (CTC). Control of these related substances in the finished ointment is therefore a critical quality attribute.

This review surveys the pharmacopoeial requirements and the published chromatographic methods for tetracycline and its related substances, from early silica-based RP-HPLC and poly(styrene-divinylbenzene) methods to modern C18 gradient, porous graphitic carbon, silica-hydride, fluorescence and HPTLC approaches. For each method the chromatographic conditions, validation findings and limitations are summarised.

Most published methods were developed for the drug substance, capsules or oral suspensions; few address the ointment matrix, and none reports a fully validated, stability-indicating related-substances method specific to the 1% ophthalmic ointment. Gaps include incomplete impurity coverage (most dosage-form methods control only EATC), lack of validated extraction from the paraffin base, solution instability during analysis, reliance on high-temperature polymeric columns and ion-pairing agents, and absence of ICH Q2(R2)/Q14-aligned validation and forced degradation in the ointment matrix. A development strategy is proposed to close these gaps.

Dimensions

Published

2026-11-13

How to Cite

Aishwarya, Duddagi Suchitra and P. Vivek Sagar (2026) “Development and Validation of an RP-HPLC Method for Estimation of Related Substances of Tetracycline Hydrochloride 1% w/w Ophthalmic Ointment: A Review”, International Journal of Pharmaceuticals and Health Care Research, 14(4), pp. 1054–1065. doi: 10.61096/ijphr.v14.iss4.2026.1054-1065.

Issue

Section

Articles